| Diabetic patients (n = 10) | Non-diabetic patients (n = 10) | P value |
---|---|---|---|
Total Cholesterol (mg/dl) | 163 ± 25 | 176 ± 30 | N.S. |
LDL (mg/dl) | 94 ± 27 | 99 ± 26 | N.S. |
Triglycerides (mg/dl) | 141 ± 40 | 142 ± 90 | N.S. |
HDL (mg/dl) | 41 ± 10 | 50 ± 12 | N.S. |
hCRP (mg/dl) | 5.2 ± 3.7 | 2.8 ± 1.8 | 0.1 |
Hemoglobin A1c level (%) | 7.73 | Â | Â |
Mean Age (years) | 67.3 | 67.7 | N.S. |
Females (%) | 40 | 50 | N.S. |
Males (%) | 60 | 50 | N.S. |
Hypertension (%) | 90 | 90 | N.S. |
Hyperlipidemia (%) | 100 | 80 | N.S. |
Smoking history (%) | 60 | 45 | N.S. |
Ischemic heart disease (%) | 60 | 60 | N.S. |
History of cerebrovascular disease (%) | 50 | 40 | N.S. |
Known PVD (%) | 30 | 20 | N.S. |
Aspirin/clopidogrel (% treated) | 90 | 100 | N.S. |
Warfarin (% treated) | 20 | 20 | N.S. |
Beta Blockers (% treated) | 70 | 80 | N.S. |
Calcium Channel Blockers (% treated) | 50 | 50 | N.S. |
Angiotensin receptors blockers/ACE-inhibitors (% treated) | 50 | 70 | N.S. |
Statins (% treated) | 100 | 90 | N.S. |
Hypoglycemic drugs (% treated) | 90 | 0 | <0.01 |
Symptomatic and asymptomatic patients (%) | 30% symptomatic | 30% symptomatic | N.S. |
70% asymptomatic | 70% asymptomatic | ||
Time elapsed from diagnosis leading to endaterectomy (weeks) | 5.9 ± 6.7 | 6.6 ± 7.8 | N.S. |